agilon health appoints Jeffrey Schwaneke to Board, filling vacancy

agilon health, inc.

Michael Smith resigned from the Board effective August 10, 2022, with no disagreement.
Jeffrey A. Schwaneke appointed as Class I director, term expiring at 2025 annual meeting.
Schwaneke also appointed to the Audit Committee.
Schwaneke is former EVP/CFO/Treasurer of Centene Corporation and a CPA.
No arrangement or understanding existed with any third party regarding his selection.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jeffrey A. Schwaneke

Director

AGL · agilon health, inc.

Effective: 2022-08-10
Filed: August 10, 2022, 7:59 PM ET

Effective August 10, 2022, Jeffrey A. Schwaneke was appointed to the Board as a Class I director

Departed

Michael Smith

Director

AGL · agilon health, inc.

Effective: 2022-08-10
Successor: Jeffrey A. Schwaneke
Filed: August 10, 2022, 7:59 PM ET

Effective August 10, 2022, Michael Smith, age 74, resigned from the board of directors (the “Board”) of agilon health, inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey A. Schwaneke was appointed as Director at agilon health, inc..

Action: appointed
Role: Director

Exact text from the filing

Effective August 10, 2022, Jeffrey A. Schwaneke was appointed to the Board as a Class I director

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Smith resigned as Director at agilon health, inc..

Action: resigned
Role: Director

Exact text from the filing

Effective August 10, 2022, Michael Smith, age 74, resigned from the board of directors (the “Board”) of agilon health, inc.

View on SEC.gov

agilon health, inc. filing history →

Source: SEC EDGAR

accession 0001193125-22-217391

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.